Baird Financial Group
SMTI icon

Baird Financial Group’s Sanara MedTech SMTI Stock Holding History

Baird Financial Group’s Portfolio SMTI Stock Details SMTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$362K Sell
21,075
-739,218
-97% -$15.2M ﹤0.01% 1580
2025
Q4 		$17.8M Buy
+760,293
New +$19.6M 0.03% 402

Other funds holding SMTI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SWM
Stonebridge Wealth Management Oak Brook, Illinois $112M AUM 23.07% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Baird Financial Group's SMTI Position: Q1 2026 in Review

Baird Financial Group reduced its Sanara MedTech (SMTI) stake by 97% in Q1 2026, selling an estimated $15.2M and leaving 21,075 shares worth $362K. The position accounts for ﹤0.01% of the portfolio, ranked #1580.

Baird Financial Group first reported a position in SMTI in Q4 2025 and has held it in 2 quarters since. The position peaked at $17.8M in Q4 2025. 65 funds tracked by Wall St. Rank hold SMTI as of Q1 2026.

  • Baird Financial Group held 21,075 shares of Sanara MedTech worth $362K as of Q1 2026.
  • Baird Financial Group sold 739,218 Sanara MedTech shares in Q1 2026, an estimated $15.2M.
  • Sanara MedTech made up ﹤0.01% of Baird Financial Group's portfolio in Q1 2026, its #1580 holding.
  • Baird Financial Group first reported a position in Sanara MedTech in Q4 2025 and has held it in 2 quarters since.
  • Baird Financial Group's Sanara MedTech position peaked at $17.8M in Q4 2025.
  • 65 funds tracked by Wall St. Rank held Sanara MedTech as of Q1 2026.

Based on Baird Financial Group's 13F filing for Q1 2026, filed 14 May 2026.